1. Dr. David Kerr. Colorectale kanker oncoloog. Biografie. 0
Dr. David Kerr, MD, explains the major recent advances in precision oncology for colon and rectal cancer. He details the evolution from broad chemotherapy to...
▶⏸
2. Vooruitgang in de behandeling van colorectale kanker. Belang van multidisciplinair team. 1
Dr. David Kerr, MD, explains how the multidisciplinary team (MD T) approach is the most significant advance in treatment, improving diagnosis, surgical quality, and the...
▶⏸
3. Colorectale kanker. Nieuwe gerichte opties voor EGFR-chemotherapie. 2
Dr. David Kerr, MD, explains how targeted chemotherapy medications like EGFR inhibitors and anti-angiogenesis drugs have transformed outcomes for metastatic colorectal cancer, extending median life...
Dr. David Kerr, MD, explains how molecular profiling and microsatellite instability (MSI) testing are critical for personalizing stage 2 colorectal cancer treatment, helping to identify...
▶⏸
5. Colorectale kanker therapie. Tumorbiomarkers en beste behandeling. 3
Dr. David Kerr, MD, explains how tumor biomarkers like KRAS, NRAS, and microsatellite instability (MSI) are essential for selecting the best chemotherapy and avoiding unnecessary...
▶⏸
6. Prognose van colorectale kanker. Hoe de toxiciteit van kankerbehandeling te voorspellen? 4
Dr. David Kerr, MD, explains how genetic profiling of both the tumor and the patient can predict chemotherapy efficacy and toxicity, enabling true personalized medicine....
▶⏸
7. Behandeling van darmkanker met aspirine. Preventie van colorectale kanker. 6
Dr. David Kerr, MD, explains how low-dose aspirin can prevent relapse after initial therapy, particularly for patients with a specific PIK3C gene mutation. He details...
▶⏸
8. Kankerbehandeling in ontwikkelingslanden. 7
Dr. David Kerr, MD, explains how to revolutionize cancer care in developing countries through prevention, point-of-care diagnostics, and innovative, low-cost treatment strategies. With over 70%...
▶⏸
9. Colorectale kanker. Behandelingsopties voor precisiemedicijnen. De toekomst. 8
Dr. David Kerr, MD, explains how the future of colon cancer treatment hinges on wider adoption of molecular prognostic markers, better patient selection for chemotherapy,...
Verfijn uw behandelplan tot in de puntjes door een panel van 3 tot 10+ topartsen die perfect bij u passen.
